The global transfection technologies market size reached US$ 1,080.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,747.7 Million by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028. More Info:- https://www.imarcgroup.com/transfection-technologies-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Transfection
Technologies Market
Research and Forecast
Report 2023-2028
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Transfection Technologies Market Research Report:
The latest report by IMARC, titled “Transfection Technologies Market: Global Industry Trends, Share,
Size, Growth, Opportunity and Forecast 2023-2028” " the global transfection technologies market
reached a value of US$ 1,080.2 Million in 2022.
Transfection is a process involving the introduction of foreign nucleic acids, such as Deoxyribonucleic
Acid (DNA), Ribonucleic Acid (RNA) and oligonucleotides, into the eukaryotic cells by nonviral methods.
It is done by using various physical, chemical and biological methods to modify certain properties of
the cell.
It is widely used for genomic studies, including cell representation, RNA interference and in vitro
research. Apart from this, it can also be employed for the bio-production of vaccines and proteins. The
utilization of innovative transfection technologies has led to their increasing applications in drug
discovery, target validation and cellular research.
Request Free Sample Report: https://www.imarcgroup.com/transfection-technologies-
market/requestsample

4. Report Description
Report Description and Highlights
Global Transfection Technologies Market Trends:
The market is primarily driven by the increasing incidences of cancer and various lifestyle disorders. The process of
transfection is widely used for the development of stem cell and gene-based therapies, which are widely used for the
treatment of numerous medical ailments. Apart from this, reagent-based transfection methods are gaining
widespread prominence across the globe as they are not only affordable but are also easier to administer in the
patient’s body. This, along with the increasing research and development (R&D) in the field of cell-based therapies, is
providing a thrust to the market growth. The market is further driven by the incorporation of advanced methods with
transfection technologies. This has enabled researchers to analyze the function of a particular gene or gene product
by enhancing or inhibiting its expression.
Moreover, these improvements have enabled them to study the function of multiple genes simultaneously within a
cell, as well as to upscale the production of recombinant proteins. There have also been significant advancements in
recombinant technology and proteomics, which is further creating a positive outlook for the market. Some of the
other factors contributing to the market growth include the development of novel techniques used for transient
transfection with improved stability and minimal off-target effects, along with the increasing investments by both the
private and government organizations to develop large scale transfection facilities. On account of the aforementioned
factors, the market is anticipated to grow at a CAGR of 8.5% during 2023-2028.
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2023-2028).

5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Product Type:
• Reagent
• Instrument
• Others
Breakup by Application:
• Therapeutic Delivery
• Bio-Medical Research
• Protein Production
• Others
Breakup by Transfection Method:
• Lipofection
• Eletroporation
• Nucleofection
• Cotransfection
• Cationic Lipid Transfection

6. Report Description
Report Description and Highlights
• In-Vivo Transfection
• Others
Breakup by Technology:
• Physical Transfection
• Biochemical Based Transfection
• Viral-Vector Based Transfection
Breakup by End-User:
• Research Centers and Academic Institutes
• Hospitals and Clinics
• Pharmaceutical and Biotechnology Companies
• Others
Breakup by Region:
• North America
• United States
• Canada
• Asia Pacific
• China

7. Report Description
Report Description and Highlights
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

8. Competitive Landscape with Key Players:
• Agilent Technologies Inc
• Bio-RAD Laboratories Inc.
• Lonza Group AG
• Maxcyte Inc.
• Mirus Bio LLC
• Polyplus Transfection
• Promega Corporation
• Roche Holding AG
• Sigma-Aldrich Corporation
• Thermo Fisher Scientific Inc.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/transfection-technologies-
market
Report Description
Report Description and Highlights

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us